Meropenem permeation through the outer membrane of pseudomonas aeruginosa can involve pathways other than the oprd porin channel

Chemotherapy

Volumn 42, Issue 3, 1996, Pages 210-214

  Perez F J ^a   Gimeno, C ^a   Navarro, D ^a   Garcia De Lomas J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Meropenem; OprD; Porin; Pseudomonas aeruginosa

Indexed keywords

CARBAPENEM DERIVATIVE; IMIPENEM; MEROPENEM; OUTER MEMBRANE PROTEIN; PORIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL OUTER MEMBRANE; DRUG PENETRATION; DRUG UPTAKE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0030007993     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239444     Document Type: Article

References (31)

1. Moellering RC, Eliopoulos GM, Sentocnick DE: The carbapencms: New broad spectrum ß-lactam antibiotics. J Antimicrob Chemother 1989;24(suppl A): 1-7.
2. Lynch MJ, Drusano GL, Mobley HLT: Emergence of resistance to imipenem in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1987;31:1892-1896.
3. Margaret BS, Drusano GL, Standi-ford HC: Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa. J Antimicrob Chemother 1989;24(suppl A): 161-167.
4. Quinn JP, Dudek EJ, DiVicenzo CA, Lucks DA, Lerner SA: Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infection. J Infect Dis 1986;154:289-294.
5. Büscher KH, Cullman WD, Dick W, Opfcrkuch W: Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrob Agents Chemother 1987;31: 703-708.
6. Studemeister AE, Quinn JP: Selective imipenem resistance in Pseudomonas aeruginosa associated with diminished outer membrane permeability. Antimicrob Agents Chemother 1988;32:1267-1268.
7. Trias J, Dufresne J, Levesque RC, Nikaido H: Decreased outer membrane permeability in imipcncm-rc-sistant mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1989;33:1201-1206.
8. Zhou XY, Kitzis MD, Guttmann L: Role of cephalosporinase in carba-pcnem resistance of clinical isolates of Pseudomonas aeruginosa. Anti-microb Agents Chemother 1993:37: 1387-1389.
9. Livermore DM: Interplay of impermeability and chromosomal ß-lacta-mase activity in imipenem-resistant Pseudomonas aeruginosa. Antimi-crob Agents Chemother 1993:36: 2046-2048.
10. Satake SH, Yoneyama H, Nakae T: Role of OmpD2 and chromosomal ß-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 1991;28:199-207.
11. Yoshihara E, Nakae T: Identification of porins in the outer membrane of Pseudomonas aeruginosa that form small diffusion pores. J Biol Chem 1989;264:6297-6301.
12. Nikaido H, Nikaido K, Harayama S: Identification and characterization of porins in Pseudomonas aeruginosa. J Biol Chem 1990:266:770-779.
13. Trias J, Nikaido H: Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penents through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990;34:52-57.
14. Satake S, Yoshihara E, Nahae T: Diffusion of plactam antibiotics through liposome membranes reconstituted from purified porins of the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990;34:685-690.
15. Fukuoka T, Ohya S, Narita T, Kat-suta M, Iijima M, Masuda N: Activity of the carbapenem panimipcncm and role of OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother 1993; 37:322-327.
16. Huang H, Hancock RE: Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosa. J Bacteriol 1993;175:7793-7800.
17. Trias J, Nikaido H: Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. J Biol Chem 1990;265:15680-15684.
18. Quinn JP, Studemeister AE, DiVi-cenzo CA, Lemer SA: Resistance to imipenem in Pseudomonas aeruginosa: Clinical experience and biochemical mechanisms. Rev Infect Dis 1988:10:892-898.
19. Livermore DM, Yang YJ: Comparative activity of mcropcnem against Pseudomonas aeruginosa strains with well characterized resistance mechanisms. J Antimicrob Chemother 1989;24(suppl A): 191-198.
20. Piddock UV, Turner HL: Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapcncm-resistant Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 1992; 11:1186-1191.
21. Quinn JP, Darzins D, Miyashiro S, Ripp S, Miller RV: Imipenem resistance in Pseudomonas aeruginosa PAO: Mapping of the OprD2 gene. Antimicrob Agents Chemother 1991;35:753-755.
22. Masuda N, Ohya S: Cross resistance to meropenem, cephems, and quino-lones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992;36:1847-1851.
23. Sumita Y, Fukasawa M: Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis. Antimicrob Agents Chemother 1993;37:2743-2746.
24. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, ed 3. Approved standard M7-A3. Villanova, NCCLS, 1993.
25. Bradford M: A rapid sensitive method for the quantitation of microgram quantities of protein-dye binding. Anal Biochem 1976;72:248-254.
26. Plikaytis BD, Carlonc GM, Edmonds P, Mayer LW: Robust estimation of standard curves for protein molecular weight and linear-duplex DNA base pair number after gel electrophoresis. Anal Biochcm 1986;152:346-364.
27. Yoneyama H, Nakae T: Mechanism of efficient elimination of protein D2 in outer membrane of imipen-cm-rcsistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1993;37:2385-2390.
28. Fung-Tomc JC, Gradclski E, Kolek B, Minassian B, Pucci M, Kessler RE, Bonner DP: Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2. Antimicrob Agents Chemother 1995;39: 386-393.
29. Fung-Tomc JC, Huczko E, Banville J, Menard M, Kolek B, Gradclski E, Kessler RE, Bonner DP: Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995;39:394-399.
30. Chen HY, Livermore DM: In vitro activity of biapenem compared with imipenem and meropenem against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. J Antimicrob Chemother 1994;33:949-958.
31. Voutsinas D, Mavroudis T, Avalmis A, Giamarcllou H: In vitro activity of meropenem. a new carbapenem. against multi-resistant Pseudomonas aeruginosa compared with that of other antipseudomonal antimicrobials. J Antimicrob Chemother 1989;24(suppl A): 197-205.